By KATIE THOMAS
The case of Exondys 51 poses emotionally charged issues for families of young boys with a rare illness, who are fighting companies to get coverage for an expensive drug approved on a lower bar of proof.
Published: June 21, 2017 at 08:00PM
from NYT Health http://ift.tt/2s1g0DT
via IFTTT
from WordPress http://ift.tt/2sHk7qB
via IFTTT
No comments:
Post a Comment